| Year |
Citation |
Score |
| 2023 |
Hassin O, Sernik M, Seligman A, Vogel FCE, Wellenstein MD, Smollich J, Halperin C, Pirona AC, Toledano LN, Caballero CD, Schlicker L, Salame TM, Sarusi Portuguez A, Aylon Y, Scherz-Shouval R, ... ... Oren M, et al. p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells. Proceedings of the National Academy of Sciences of the United States of America. 120: e2311460120. PMID 38127986 DOI: 10.1073/pnas.2311460120 |
0.341 |
|
| 2022 |
Hassin O, Oren M. Drugging p53 in cancer: one protein, many targets. Nature Reviews. Drug Discovery. PMID 36216888 DOI: 10.1038/s41573-022-00571-8 |
0.383 |
|
| 2022 |
Mukherjee S, Maddalena M, Lü Y, Martinez S, Nataraj NB, Noronha A, Sinha S, Teng K, Cohen-Kaplan V, Ziv T, Arandkar S, Hassin O, Chatterjee R, Pirona AC, Shreberk-Shaked M, ... ... Oren M, et al. Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins. Proceedings of the National Academy of Sciences of the United States of America. 119: e2119644119. PMID 35439056 DOI: 10.1073/pnas.2119644119 |
0.471 |
|
| 2021 |
Maddalena M, Mallel G, Nataraj NB, Shreberk-Shaked M, Hassin O, Mukherjee S, Arandkar S, Rotkopf R, Kapsack A, Lambiase G, Pellegrino B, Ben-Isaac E, Golani O, Addadi Y, Hajaj E, ... ... Oren M, et al. missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34088837 DOI: 10.1073/pnas.2025631118 |
0.317 |
|
| 2020 |
Shaked MS, Dassa B, Sinha S, Di Agostino S, Azuri I, Mukherjee S, Aylon Y, Blandino G, Ruppin E, Oren M. A division of labor between YAP and TAZ in non-small cell lung cancer. Cancer Research. PMID 32816858 DOI: 10.1158/0008-5472.Can-20-0125 |
0.351 |
|
| 2020 |
Kadosh E, Snir-Alkalay I, Venkatachalam A, May S, Lasry A, Elyada E, Zinger A, Shaham M, Vaalani G, Mernberger M, Stiewe T, Pikarsky E, Oren M, Ben-Neriah Y. The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic. Nature. PMID 32728212 DOI: 10.1038/S41586-020-2541-0 |
0.476 |
|
| 2020 |
Benor G, Fuks G, Chin SF, Rueda OM, Mukherjee S, Arandkar S, Aylon Y, Caldas C, Domany E, Oren M. Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features. Molecular Oncology. PMID 32484602 DOI: 10.1002/1878-0261.12736 |
0.447 |
|
| 2020 |
Furth N, Pateras I, Rotkopf R, Schmitt I, Bakaev D, Gershoni A, Johnson R, Gorgoulis V, Oren M, Aylon Y. Abstract IA20: LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Hippo19-Ia20 |
0.346 |
|
| 2020 |
Shreberk-Shaked M, Dassa B, Agostino SD, Nuriel Y, Wigoda N, Rotkopf R, Blandino G, Aylon Y, Oren M. Abstract B43: Division of labor between YAP and TAZ in lung cancer Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Hippo19-B43 |
0.326 |
|
| 2019 |
Oren M. p53: not just a tumor suppressor. Journal of Molecular Cell Biology. PMID 31291648 DOI: 10.1093/Jmcb/Mjz070 |
0.496 |
|
| 2019 |
Shreberk-Shaked M, Oren M. New insights into YAP/TAZ nucleo-cytoplasmic shuttling: New cancer therapeutic opportunities? Molecular Oncology. PMID 31050214 DOI: 10.1002/1878-0261.12498 |
0.305 |
|
| 2019 |
Weisz L, Zalcenstein A, Stambolsky P, Cohen Y, Goldfinger N, Oren M, Rotter V. Retraction: Transactivation of the Gene Contributes to Mutant p53 Gain of Function. Cancer Research. 79: 2085. PMID 30987981 DOI: 10.1158/0008-5472.Can-19-0560 |
0.328 |
|
| 2019 |
Oren M, Arandkar S, Benor G, Furth N, Aylon Y, Domany E. Abstract SY32-02: Modulation of wild-type p53 activity in cancer cells and in the tumor microenvironment Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-Sy32-02 |
0.484 |
|
| 2019 |
Silverman DA, Ashkin E, Whitfield B, Punt S, Manrique SZ, Wang Y, Korkut A, Williams L, Zhang M, Kotler E, Oren M, Maitra A, Hwu P. Abstract 2372: Tumoral p53 mutations differentially mediate poor T-cell infiltration and autologous T-cell killing in preclinical models Immunology. DOI: 10.1158/1538-7445.Sabcs18-2372 |
0.391 |
|
| 2018 |
Furth N, Aylon Y, Oren M. p53 shades of Hippo. Cell Death and Differentiation. 25: 81-92. PMID 31745317 DOI: 10.1038/cdd.2017.163 |
0.443 |
|
| 2018 |
Hooda J, Novak M, Salomon MP, Matsuba C, Ramos RI, MacDuffie E, Song M, Hirsch MS, Lester J, Parkash V, Karlan BY, Oren M, Hoon DS, Drapkin R. Early loss of Histone H2B monoubiquitylation alters chromatin accessibility and activates key immune pathways that facilitate progression of ovarian cancer. Cancer Research. PMID 30563893 DOI: 10.1158/0008-5472.Can-18-2297 |
0.362 |
|
| 2018 |
Kotler E, Segal E, Oren M. Functional characterization of the p53 "mutome". Molecular & Cellular Oncology. 5: e1511207. PMID 30525089 DOI: 10.1080/23723556.2018.1511207 |
0.387 |
|
| 2018 |
Minzel W, Venkatachalam A, Fink A, Hung E, Brachya G, Burstain I, Shaham M, Rivlin A, Omer I, Zinger A, Elias S, Winter E, Erdman PE, Sullivan RW, Fung L, ... ... Oren M, et al. Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models. Cell. PMID 30146162 DOI: 10.1016/J.Cell.2018.07.045 |
0.418 |
|
| 2018 |
Kotler E, Shani O, Goldfeld G, Lotan-Pompan M, Tarcic O, Gershoni A, Hopf TA, Marks DS, Oren M, Segal E. A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation. Molecular Cell. 71: 178-190.e8. PMID 29979965 DOI: 10.1016/J.Molcel.2018.06.012 |
0.445 |
|
| 2018 |
Arandkar S, Furth N, Elisha Y, Nataraj NB, van der Kuip H, Yarden Y, Aulitzky W, Ulitsky I, Geiger B, Oren M. Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features. Proceedings of the National Academy of Sciences of the United States of America. PMID 29866855 DOI: 10.1073/Pnas.1719076115 |
0.526 |
|
| 2018 |
Jethwa A, Słabicki M, Hüllein J, Jentzsch M, Dalal V, Rabe S, Wagner L, Walther T, Klapper W, Bohnenberger H, Rettel M, Lu J, Smits AH, Stein F, Savitski MM, ... ... Oren M, et al. TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma. Blood. PMID 29653964 DOI: 10.1182/Blood-2017-09-806679 |
0.536 |
|
| 2018 |
Ghannam-Shahbari D, Jacob E, Kakun RR, Wasserman T, Korsensky L, Sternfeld O, Kagan J, Bublik DR, Aviel-Ronen S, Levanon K, Sabo E, Larisch S, Oren M, Hershkovitz D, Perets R. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma. Oncogene. PMID 29379162 DOI: 10.1038/S41388-017-0040-Z |
0.512 |
|
| 2018 |
Solomon H, Dinowitz N, Pateras IS, Cooks T, Shetzer Y, Molchadsky A, Charni M, Rabani S, Koifman G, Tarcic O, Porat Z, Kogan-Sakin I, Goldfinger N, Oren M, Harris CC, et al. Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers. Oncogene. PMID 29343849 DOI: 10.1038/S41388-017-0060-8 |
0.499 |
|
| 2017 |
Shema E, Tirosh I, Aylon Y, Huang J, Ye C, Moskovits N, Raver-Shapira N, Minsky N, Pirngruber J, Tarcic G, Hublarova P, Moyal L, Gana-Weisz M, Shiloh Y, Yarden Y, ... ... Oren M, et al. Corrigendum: The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes & Development. 31: 1926. PMID 29051390 DOI: 10.1101/gad.307207.117 |
0.721 |
|
| 2017 |
Enuka Y, Feldman ME, Chowdhury A, Srivastava S, Lindzen M, Sas-Chen A, Massart R, Cheishvili D, Suderman MJ, Zaltsman Y, Mazza CA, Shukla K, Körner C, Furth N, Lauriola M, ... Oren M, et al. Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone. Nucleic Acids Research. PMID 29036586 DOI: 10.1093/Nar/Gkx865 |
0.378 |
|
| 2017 |
Aylon Y, Oren M. Tumor Suppression by p53: Bring in the Hippo! Cancer Cell. 32: 397-399. PMID 29017051 DOI: 10.1016/J.Ccell.2017.09.010 |
0.517 |
|
| 2017 |
Furth N, Aylon Y, Oren M. p53 shades of Hippo. Cell Death and Differentiation. PMID 28984872 DOI: 10.1038/Cdd.2017.163 |
0.535 |
|
| 2017 |
Tovy A, Spiro A, McCarthy R, Shipony Z, Aylon Y, Alton K, Ainbinder E, Furth N, Tanay A, Barton M, Oren M. p53 is essential for DNA methylation homeostasis in naïve embryonic stem cells, and its loss promotes clonal heterogeneity. Genes & Development. PMID 28607180 DOI: 10.1101/Gad.299198.117 |
0.451 |
|
| 2017 |
Spolverini A, Fuchs G, Bublik DR, Oren M. let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery. Oncogene. PMID 28604753 DOI: 10.1038/Onc.2017.187 |
0.37 |
|
| 2017 |
Tarcic O, Granit RZ, Pateras IS, Masury H, Maly B, Zwang Y, Yarden Y, Gorgoulis VG, Pikarsky E, Ben-Porath I, Oren M. RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer. Cell Death and Differentiation. PMID 28157208 DOI: 10.1038/Cdd.2016.126 |
0.358 |
|
| 2017 |
Hood J, Novak M, MacDuffie E, Lester J, Parkash V, Mills GB, Karlan BY, Oren M, Drapkin R. Abstract MIP-060: EPIGENETIC DYSREGULATION OF A HISTONE MARK REVEALS A METABOLIC VULNERABILITY IN OVARIAN CANCER Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Ovcasymp16-Mip-060 |
0.357 |
|
| 2016 |
Bublik DR, Bursać S, Sheffer M, Oršolić I, Shalit T, Tarcic O, Kotler E, Mouhadeb O, Hoffman Y, Fuchs G, Levin Y, Volarević S, Oren M. Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival. Proceedings of the National Academy of Sciences of the United States of America. PMID 27994142 DOI: 10.1073/Pnas.1614876114 |
0.431 |
|
| 2016 |
Isaac R, Goldstein I, Furth N, Zilber N, Streim S, Boura-Halfon S, Elhanany E, Rotter V, Oren M, Zick Y. TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein response. Cell Death and Differentiation. PMID 27740623 DOI: 10.1038/Cdd.2016.108 |
0.519 |
|
| 2016 |
Oren M, Kotler E. p53 mutations promote proteasomal activity. Nature Cell Biology. 18: 833-5. PMID 27463250 DOI: 10.1038/Ncb3392 |
0.459 |
|
| 2016 |
Aylon Y, Oren M. The Hippo Pathway, p53 and Cholesterol. Cell Cycle (Georgetown, Tex.). 0. PMID 27419353 DOI: 10.1080/15384101.2016.1207840 |
0.447 |
|
| 2016 |
Aylon Y, Oren M. The Paradox of p53: What, How, and Why? Cold Spring Harbor Perspectives in Medicine. PMID 27413116 DOI: 10.1101/Cshperspect.A026328 |
0.554 |
|
| 2016 |
Simerzin A, Zorde-Khvalevsky E, Rivkin M, Adar R, Zucman-Rossi J, Couchy G, Roskams T, Govaere O, Oren M, Giladi H, Galun E. The liver-specific miR-122*, the complementary strand of miR-122, acts as a tumor suppressor by modulating the p53-Mdm2 circuitry. Hepatology (Baltimore, Md.). PMID 27302319 DOI: 10.1002/Hep.28679 |
0.371 |
|
| 2016 |
Aylon Y, Gershoni A, Rotkopf R, Biton IE, Porat Z, Koh AP, Sun X, Lee Y, Fiel MI, Hoshida Y, Friedman SL, Johnson RL, Oren M. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation. Genes & Development. PMID 27013235 DOI: 10.1101/Gad.274167.115 |
0.345 |
|
| 2016 |
Tal P, Eizenberger S, Cohen E, Goldfinger N, Pietrokovski S, Oren M, Rotter V. Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides. Oncotarget. PMID 26943582 DOI: 10.18632/Oncotarget.7857 |
0.481 |
|
| 2016 |
Hoffman Y, Bublik DR, P Ugalde A, Elkon R, Biniashvili T, Agami R, Oren M, Pilpel Y. 3'UTR Shortening Potentiates MicroRNA-Based Repression of Pro-differentiation Genes in Proliferating Human Cells. Plos Genetics. 12: e1005879. PMID 26908102 DOI: 10.1371/Journal.Pgen.1005879 |
0.335 |
|
| 2016 |
Tarcic O, Pateras IS, Cooks T, Shema E, Kanterman J, Ashkenazi H, Boocholez H, Hubert A, Rotkopf R, Baniyash M, Pikarsky E, Gorgoulis VG, Oren M. RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer. Cell Reports. PMID 26854224 DOI: 10.1016/J.Celrep.2016.01.020 |
0.396 |
|
| 2016 |
Oren M, Furth N, Ben-Moshe NB, Porat Z, Domany E, Pozniak Y, Geiger T, Aylon Y. Abstract SY26-03: Tumor suppressor crosstalk: Modulation of p53 activity by the Hippo pathway Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Sy26-03 |
0.609 |
|
| 2016 |
Furth N, Bossel N, Pozniak Y, Geiger T, Domany E, Aylon Y, Oren M. Tumor suppressor crosstalk: Hippo and p53 European Journal of Cancer. 61: S50. DOI: 10.1016/S0959-8049(16)61166-8 |
0.497 |
|
| 2015 |
Orsolic I, Jurada D, Pullen N, Oren M, Eliopoulos AG, Volarevic S. The relationship between the nucleolus and cancer: Current evidence and emerging paradigms. Seminars in Cancer Biology. PMID 26721423 DOI: 10.1016/J.Semcancer.2015.12.004 |
0.407 |
|
| 2015 |
Furth N, Bossel Ben-Moshe N, Pozniak Y, Porat Z, Geiger T, Domany E, Aylon Y, Oren M. Down-regulation of LATS kinases alters p53 to promote cell migration. Genes & Development. 29: 2325-30. PMID 26588988 DOI: 10.1101/Gad.268185.115 |
0.575 |
|
| 2015 |
Oren M, Damalas A, Gottlieb T, Michael D, Taplick J, Martinez Leal JF, Maya R, Moas M, Seger R, Taya Y, Ben-Ze'ev A. Retraction notice to "Regulation of p53: Intricate loops and delicate balances" [Biochem. Pharmacol. 64 (2002) 865-871]. Biochemical Pharmacology. 96: 369. PMID 26465018 DOI: 10.1016/J.Bcp.2015.07.001 |
0.503 |
|
| 2015 |
Blume CJ, Hotz-Wagenblatt A, Hüllein J, Sellner L, Jethwa A, Stolz T, Slabicki M, Lee K, Sharathchandra A, Benner A, Dietrich S, Oakes CC, Dreger P, Te Raa D, Kater AP, ... ... Oren M, et al. p53-dependent non-coding RNA networks in Chronic Lymphocytic Leukemia. Leukemia. PMID 25971364 DOI: 10.1038/Leu.2015.119 |
0.506 |
|
| 2015 |
Adi Harel S, Bossel Ben-Moshe N, Aylon Y, Bublik DR, Moskovits N, Toperoff G, Azaiza D, Biagoni F, Fuchs G, Wilder S, Hellman A, Blandino G, Domany E, Oren M. Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth. Cell Death and Differentiation. 22: 1328-40. PMID 25591738 DOI: 10.1038/Cdd.2014.221 |
0.702 |
|
| 2014 |
Weilbacher A, Gutekunst M, Oren M, Aulitzky WE, Kuip Hvd. RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38. Cell Death and Disease. 5. PMID 25010984 DOI: 10.1038/Cddis.2014.284 |
0.582 |
|
| 2014 |
Cooks T, Harris CC, Oren M. Caught in the cross fire: p53 in inflammation. Carcinogenesis. 35: 1680-90. PMID 24942866 DOI: 10.1093/Carcin/Bgu134 |
0.542 |
|
| 2014 |
Hoffman Y, Pilpel Y, Oren M. microRNAs and Alu elements in the p53-Mdm2-Mdm4 regulatory network. Journal of Molecular Cell Biology. 6: 192-7. PMID 24868102 DOI: 10.1093/Jmcb/Mju020 |
0.452 |
|
| 2014 |
Golomb L, Volarevic S, Oren M. p53 and ribosome biogenesis stress: the essentials. Febs Letters. 588: 2571-9. PMID 24747423 DOI: 10.1016/J.Febslet.2014.04.014 |
0.419 |
|
| 2014 |
Aylon Y, Sarver A, Tovy A, Ainbinder E, Oren M. Lats2 is critical for the pluripotency and proper differentiation of stem cells. Cell Death and Differentiation. 21: 624-33. PMID 24413153 DOI: 10.1038/Cdd.2013.188 |
0.364 |
|
| 2014 |
Fuchs G, Oren M. Writing and reading H2B monoubiquitylation. Biochimica Et Biophysica Acta. 1839: 694-701. PMID 24412854 DOI: 10.1016/J.Bbagrm.2014.01.002 |
0.303 |
|
| 2014 |
Hoffman Y, Bublik DR, Pilpel Y, Oren M. MiR-661 downregulates both Mdm2 and Mdm4 to activate p53 Cell Death and Differentiation. 21: 302-309. PMID 24141721 DOI: 10.1038/Cdd.2013.146 |
0.418 |
|
| 2014 |
Weingarten-Gabbay S, Khan D, Liberman N, Yoffe Y, Bialik S, Das S, Oren M, Kimchi A. The translation initiation factor DAP5 promotes IRES-driven translation of p53 mRNA Oncogene. 33: 611-618. PMID 23318444 DOI: 10.1038/Onc.2012.626 |
0.475 |
|
| 2014 |
Shapira S, Shapira A, Kazanov D, Kraus S, Oren M, Arber N. 873 The “Trojan Horse” Strategy: Selective Eradication of Cancer Cells by Adenovirus-Based Delivery of Cytotoxic Agents: An Alternative Method for Targeting Pancreatic (PC) and Colorectal Cancers (CRC) Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)60540-0 |
0.355 |
|
| 2014 |
Lasry A, Aran D, Zinger A, Hamza H, Kadosh E, Elyada E, Pribluda A, Hellman A, Oren M, Pikarsky E, Ben-Neriah Y. S-6 Cytokine. 70: 22. DOI: 10.1016/J.Cyto.2014.07.226 |
0.366 |
|
| 2013 |
Golomb L, Oren M. In the race for protection, ARF comes second Cell Death and Differentiation. 20: 1442-1443. PMID 24096933 DOI: 10.1038/Cdd.2013.117 |
0.518 |
|
| 2013 |
Fausti F, Di Agostino S, Cioce M, Bielli P, Sette C, Pandolfi PP, Oren M, Sudol M, Strano S, Blandino G. ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescence. Cell Death and Differentiation. 20: 1498-509. PMID 23933816 DOI: 10.1038/Cdd.2013.101 |
0.482 |
|
| 2013 |
Shema-Yaacoby E, Nikolov M, Haj-Yahya M, Siman P, Allemand E, Yamaguchi Y, Muchardt C, Urlaub H, Brik A, Oren M, Fischle W. Systematic identification of proteins binding to chromatin-embedded ubiquitylated H2B reveals recruitment of SWI/SNF to regulate transcription. Cell Reports. 4: 601-8. PMID 23933260 DOI: 10.1016/J.Celrep.2013.07.014 |
0.353 |
|
| 2013 |
Pribluda A, Elyada E, Wiener Z, Hamza H, Goldstein RE, Biton M, Burstain I, Morgenstern Y, Brachya G, Billauer H, Biton S, Snir-Alkalay I, Vucic D, Schlereth K, Mernberger M, ... ... Oren M, et al. A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell. 24: 242-56. PMID 23890787 DOI: 10.1016/J.Ccr.2013.06.005 |
0.415 |
|
| 2013 |
Suzuki H, Yabuta N, Okada N, Torigata K, Aylon Y, Oren M, Nojima H. Lats2 phosphorylates p21/CDKN1A after UV irradiation and regulates apoptosis. Journal of Cell Science. 126: 4358-68. PMID 23886938 DOI: 10.1242/Jcs.125815 |
0.44 |
|
| 2013 |
Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S, Lozano G, Pikarsky E, Forshew T, Rosenfeld N, Rozenfeld N, Harpaz N, Itzkowitz S, Harris CC, Rotter V, ... ... Oren M, et al. Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell. 23: 634-46. PMID 23680148 DOI: 10.1016/J.Ccr.2013.03.022 |
0.441 |
|
| 2013 |
Gutekunst M, Mueller T, Weilbacher A, Dengler MA, Bedke J, Kruck S, Oren M, Aulitzky WE, van der Kuip H. Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4. Cancer Research. 73: 1460-9. PMID 23302226 DOI: 10.1158/0008-5472.Can-12-2876 |
0.536 |
|
| 2013 |
Gutekunst M, Mueller T, Weilbacher A, Dengler MA, Oren M, Aulitzky WE, Kuip Hvd. Abstract 1721: Testicular germ cell tumors are hypersensitive to p53 activation based on their Oct-4/Noxa-mediated cellular context rather than on differential p53 activity. Cancer Research. 73: 1721-1721. DOI: 10.1158/1538-7445.Am2013-1721 |
0.588 |
|
| 2012 |
Bursać S, Brdovčak MC, Pfannkuchen M, Orsolić I, Golomb L, Zhu Y, Katz C, Daftuar L, Grabušić K, Vukelić I, Filić V, Oren M, Prives C, Volarevic S. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proceedings of the National Academy of Sciences of the United States of America. 109: 20467-72. PMID 23169665 DOI: 10.1073/Pnas.1218535109 |
0.347 |
|
| 2012 |
Schmid JO, Dong M, Haubeiss S, Friedel G, Bode S, Grabner A, Ott G, Mürdter TE, Oren M, Aulitzky WE, van der Kuip H. Cancer cells cue the p53 response of cancer-associated fibroblasts to cisplatin. Cancer Research. 72: 5824-32. PMID 22962266 DOI: 10.1158/0008-5472.Can-12-1201 |
0.524 |
|
| 2012 |
Fuchs G, Shema E, Vesterman R, Kotler E, Wolchinsky Z, Wilder S, Golomb L, Pribluda A, Zhang F, Haj-Yahya M, Feldmesser E, Brik A, Yu X, Hanna J, Aberdam D, ... ... Oren M, et al. RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation. Molecular Cell. 46: 662-73. PMID 22681888 DOI: 10.1016/J.Molcel.2012.05.023 |
0.312 |
|
| 2012 |
Hornung G, Oren M, Barkai N. Nucleosome organization affects the sensitivity of gene expression to promoter mutations. Molecular Cell. 46: 362-8. PMID 22464732 DOI: 10.1016/J.Molcel.2012.02.019 |
0.319 |
|
| 2012 |
Bublik DR, Oren M. Get your fingers out of p53's way! Embo Reports. 13: 282-3. PMID 22422000 DOI: 10.1038/Embor.2012.33 |
0.521 |
|
| 2012 |
Zwang Y, Oren M, Yarden Y. Consistency test of the cell cycle: roles for p53 and EGR1. Cancer Research. 72: 1051-4. PMID 22315347 DOI: 10.1158/0008-5472.Can-11-3382 |
0.456 |
|
| 2012 |
Golomb L, Bublik DR, Wilder S, Nevo R, Kiss V, Grabusic K, Volarevic S, Oren M. Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis. Molecular Cell. 45: 222-32. PMID 22284678 DOI: 10.1016/J.Molcel.2011.11.022 |
0.524 |
|
| 2012 |
Schmid JO, Dong M, Haubeiss S, Friedel G, Oren M, Mürdter TE, Aulitzky WE, Kuip Hvd. Abstract 2869: p53 response of cancer associated fibroblasts (CAFs) to cisplatin is closely correlated with the p53 response of tumor cells in lung cancer tissue cultures Cancer Research. 72: 2869-2869. DOI: 10.1158/1538-7445.Am2012-2869 |
0.544 |
|
| 2011 |
Blandino G, Deppert W, Hainaut P, Levine A, Lozano G, Olivier M, Rotter V, Wiman K, Oren M. Mutant p53 protein, master regulator of human malignancies: a report on the Fifth Mutant p53 Workshop. Cell Death and Differentiation. 19: 180-3. PMID 22095277 DOI: 10.1038/Cdd.2011.148 |
0.486 |
|
| 2011 |
Golomb L, Oren M. DePICTing p53 activation: a new nucleolar link to cancer. Cancer Cell. 20: 283-4. PMID 21907918 DOI: 10.1016/J.Ccr.2011.08.017 |
0.533 |
|
| 2011 |
Aylon Y, Oren M. p53: guardian of ploidy. Molecular Oncology. 5: 315-23. PMID 21852209 DOI: 10.1016/J.Molonc.2011.07.007 |
0.515 |
|
| 2011 |
Shiloh Y, Shema E, Moyal L, Oren M. RNF20-RNF40: A ubiquitin-driven link between gene expression and the DNA damage response. Febs Letters. 585: 2795-802. PMID 21827756 DOI: 10.1016/J.Febslet.2011.07.034 |
0.379 |
|
| 2011 |
Rivlin N, Brosh R, Oren M, Rotter V. Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. Genes & Cancer. 2: 466-74. PMID 21779514 DOI: 10.1177/1947601911408889 |
0.539 |
|
| 2011 |
Zwang Y, Sas-Chen A, Drier Y, Shay T, Avraham R, Lauriola M, Shema E, Lidor-Nili E, Jacob-Hirsch J, Amariglio N, Lu Y, Mills GB, Rechavi G, Oren M, Domany E, et al. Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals. Molecular Cell. 42: 524-35. PMID 21596316 DOI: 10.1016/J.Molcel.2011.04.017 |
0.344 |
|
| 2011 |
Shema E, Kim J, Roeder RG, Oren M. RNF20 inhibits TFIIS-facilitated transcriptional elongation to suppress pro-oncogenic gene expression. Molecular Cell. 42: 477-88. PMID 21596312 DOI: 10.1016/J.Molcel.2011.03.011 |
0.375 |
|
| 2011 |
Tarocchi M, Hannivoort R, Hoshida Y, Lee UE, Vetter D, Narla G, Villanueva A, Oren M, Llovet JM, Friedman SL. Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation. Hepatology (Baltimore, Md.). 54: 522-31. PMID 21563203 DOI: 10.1002/Hep.24413 |
0.397 |
|
| 2011 |
Gutekunst M, Oren M, Weilbacher A, Dengler MA, Markwardt C, Thomale J, Aulitzky WE, van der Kuip H. p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin. Plos One. 6: e19198. PMID 21532991 DOI: 10.1371/Journal.Pone.0019198 |
0.573 |
|
| 2011 |
Shema E, Oren M, Minsky N. Detection and characterization of ubiquitylated H2B in mammalian cells. Methods (San Diego, Calif.). 54: 326-30. PMID 21439383 DOI: 10.1016/J.Ymeth.2011.03.005 |
0.339 |
|
| 2011 |
Moyal L, Lerenthal Y, Gana-Weisz M, Mass G, So S, Wang SY, Eppink B, Chung YM, Shalev G, Shema E, Shkedy D, Smorodinsky NI, van Vliet N, Kuster B, Mann M, ... ... Oren M, et al. Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Molecular Cell. 41: 529-42. PMID 21362549 DOI: 10.1016/J.Molcel.2011.02.015 |
0.301 |
|
| 2011 |
Dell'Orso S, Fontemaggi G, Stambolsky P, Goeman F, Voellenkle C, Levrero M, Strano S, Rotter V, Oren M, Blandino G. ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters. Omics : a Journal of Integrative Biology. 15: 305-12. PMID 21332394 DOI: 10.1089/Omi.2010.0084 |
0.551 |
|
| 2011 |
Elyada E, Pribluda A, Goldstein RE, Morgenstern Y, Brachya G, Cojocaru G, Snir-Alkalay I, Burstain I, Haffner-Krausz R, Jung S, Wiener Z, Alitalo K, Oren M, Pikarsky E, Ben-Neriah Y. CKIα ablation highlights a critical role for p53 in invasiveness control. Nature. 470: 409-13. PMID 21331045 DOI: 10.1038/Nature09673 |
0.532 |
|
| 2011 |
Aylon Y, Oren M. New plays in the p53 theater. Current Opinion in Genetics & Development. 21: 86-92. PMID 21317061 DOI: 10.1016/J.Gde.2010.10.002 |
0.564 |
|
| 2011 |
Okada N, Yabuta N, Suzuki H, Aylon Y, Oren M, Nojima H. A novel Chk1/2-Lats2-14-3-3 signaling pathway regulates P-body formation in response to UV damage. Journal of Cell Science. 124: 57-67. PMID 21118956 DOI: 10.1242/Jcs.072918 |
0.458 |
|
| 2011 |
Goldstein I, Marcel V, Olivier M, Oren M, Rotter V, Hainaut P. Understanding wild-type and mutant p53 activities in human cancer: New landmarks on the way to targeted therapies Cancer Gene Therapy. 18: 2-11. PMID 20966976 DOI: 10.1038/Cgt.2010.63 |
0.544 |
|
| 2011 |
Gutekunst M, Oren M, Weilbacher A, Dengler MA, Aulitzky WE, Kuip Hvd. Abstract 4693: High expression levels of NOXA are important for p53-mediated hypersensitivity in testicular germ cell tumor (TGCT) cells Cancer Research. 71: 4693-4693. DOI: 10.1158/1538-7445.Am2011-4693 |
0.562 |
|
| 2011 |
Oren M, Aylon Y, Shema E, Fuchs G. 229 INVITED Tumour Suppressor Networks: Lessons From p53 European Journal of Cancer. 47: S54-S55. DOI: 10.1016/S0959-8049(11)70444-0 |
0.379 |
|
| 2010 |
Aylon Y, Ofir-Rosenfeld Y, Yabuta N, Lapi E, Nojima H, Lu X, Oren M. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Genes & Development. 24: 2420-9. PMID 21041410 DOI: 10.1101/Gad.1954410 |
0.822 |
|
| 2010 |
Addadi Y, Moskovits N, Granot D, Lozano G, Carmi Y, Apte RN, Neeman M, Oren M. p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner Cancer Research. 70: 9650-9658. PMID 20952507 DOI: 10.1158/0008-5472.Can-10-1146 |
0.798 |
|
| 2010 |
Scherz-Shouval R, Weidberg H, Gonen C, Wilder S, Elazar Z, Oren M. p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proceedings of the National Academy of Sciences of the United States of America. 107: 18511-6. PMID 20937856 DOI: 10.1073/Pnas.1006124107 |
0.575 |
|
| 2010 |
Lidor Nili E, Field Y, Lubling Y, Widom J, Oren M, Segal E. p53 binds preferentially to genomic regions with high DNA-encoded nucleosome occupancy. Genome Research. 20: 1361-8. PMID 20716666 DOI: 10.1101/Gr.103945.109 |
0.747 |
|
| 2010 |
Oren M, Cooks T. NFκB and p53: A life and death affair. Cell Cycle (Georgetown, Tex.). 9: 1027. PMID 20237416 DOI: 10.4161/Cc.9.6.11099 |
0.389 |
|
| 2010 |
Schilling T, Kairat A, Melino G, Krammer PH, Stremmel W, Oren M, Müller M. Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 394: 817-23. PMID 20233581 DOI: 10.1016/J.Bbrc.2010.03.082 |
0.535 |
|
| 2010 |
Stambolsky P, Tabach Y, Fontemaggi G, Weisz L, Maor-Aloni R, Siegfried Z, Sigfried Z, Shiff I, Kogan I, Shay M, Kalo E, Blandino G, Simon I, Oren M, Rotter V. Modulation of the vitamin D3 response by cancer-associated mutant p53. Cancer Cell. 17: 273-85. PMID 20227041 DOI: 10.1016/J.Ccr.2009.11.025 |
0.457 |
|
| 2010 |
Oren M, Rotter V. Mutant p53 gain-of-function in cancer. Cold Spring Harbor Perspectives in Biology. 2: a001107. PMID 20182618 DOI: 10.1101/Cshperspect.A001107 |
0.533 |
|
| 2010 |
Bar J, Moskovits N, Oren M. Involvement of stromal p53 in tumor-stroma interactions. Seminars in Cell & Developmental Biology. 21: 47-54. PMID 19914385 DOI: 10.1016/J.Semcdb.2009.11.006 |
0.811 |
|
| 2010 |
Christoffersen NR, Shalgi R, Frankel LB, Leucci E, Lees M, Klausen M, Pilpel Y, Nielsen FC, Oren M, Lund AH. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death and Differentiation. 17: 236-45. PMID 19696787 DOI: 10.1038/Cdd.2009.109 |
0.314 |
|
| 2010 |
Stambolsky P, Tabach Y, Fontemaggi G, Weisz L, Maor-Aloni R, Siegfried Z, Shiff I, Kogan I, Shay M, Kalo E, Blandino G, Simon I, Oren M, Rotter V. Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53 (DOI:10.1016/j.ccr.2009.11.025) Cancer Cell. 17: 523. DOI: 10.1016/J.Ccr.2010.04.017 |
0.356 |
|
| 2009 |
Lavelin I, Beer A, Kam Z, Rotter V, Oren M, Navon A, Geiger B. Discovery of novel proteasome inhibitors using a high-content cell-based screening system. Plos One. 4: e8503. PMID 20041034 DOI: 10.1371/Journal.Pone.0008503 |
0.383 |
|
| 2009 |
Skorta I, Oren M, Markwardt C, Gutekunst M, Aulitzky WE, van der Kuip H. Imatinib mesylate induces cisplatin hypersensitivity in Bcr-Abl+ cells by differential modulation of p53 transcriptional and proapoptotic activity. Cancer Research. 69: 9337-45. PMID 19934315 DOI: 10.1158/0008-5472.Can-09-0548 |
0.497 |
|
| 2009 |
Aylon Y, Yabuta N, Besserglick H, Buganim Y, Rotter V, Nojima H, Oren M. Silencing of the lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation Oncogene. 28: 4469-4479. PMID 19855428 DOI: 10.1038/Onc.2009.270 |
0.463 |
|
| 2009 |
Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nature Reviews. Cancer. 9: 749-58. PMID 19776744 DOI: 10.1038/Nrc2723 |
0.521 |
|
| 2009 |
Schilling T, Schleithoff ES, Kairat A, Melino G, Stremmel W, Oren M, Krammer PH, Müller M. Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family. Biochemical and Biophysical Research Communications. 387: 399-404. PMID 19615968 DOI: 10.1016/J.Bbrc.2009.07.063 |
0.497 |
|
| 2009 |
Pirngruber J, Shchebet A, Schreiber L, Shema E, Minsky N, Chapman RD, Eick D, Aylon Y, Oren M, Johnsen SA. CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processing. Embo Reports. 10: 894-900. PMID 19575011 DOI: 10.1038/Embor.2009.108 |
0.323 |
|
| 2009 |
Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, ... ... Oren M, et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death and Differentiation. 16: 1093-107. PMID 19373242 DOI: 10.1038/Cdd.2009.44 |
0.303 |
|
| 2009 |
Bar J, Feniger-Barish R, Lukashchuk N, Shaham H, Moskovits N, Goldfinger N, Simansky D, Perlman M, Papa M, Yosepovich A, Rechavi G, Rotter V, Oren M. Cancer cells suppress p53 in adjacent fibroblasts. Oncogene. 28: 933-6. PMID 19060923 DOI: 10.1038/Onc.2008.445 |
0.809 |
|
| 2008 |
Brosh R, Shalgi R, Liran A, Landan G, Korotayev K, Nguyen GH, Enerly E, Johnsen H, Buganim Y, Solomon H, Goldstein I, Madar S, Goldfinger N, Børresen-Dale AL, Ginsberg D, ... ... Oren M, et al. p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Molecular Systems Biology. 4: 229. PMID 19034270 DOI: 10.1038/Msb.2008.65 |
0.351 |
|
| 2008 |
Ofir-Rosenfeld Y, Boggs K, Michael D, Kastan MB, Oren M. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Molecular Cell. 32: 180-9. PMID 18951086 DOI: 10.1016/J.Molcel.2008.08.031 |
0.802 |
|
| 2008 |
Shema E, Tirosh I, Aylon Y, Huang J, Ye C, Moskovits N, Raver-Shapira N, Minsky N, Pirngruber J, Tarcic G, Hublarova P, Moyal L, Gana-Weisz M, Shiloh Y, Yarden Y, ... ... Oren M, et al. The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes & Development. 22: 2664-76. PMID 18832071 DOI: 10.1101/Gad.1703008 |
0.757 |
|
| 2008 |
Bossi G, Marampon F, Maor-Aloni R, Zani B, Rotter V, Oren M, Strano S, Blandino G, Sacchi A. Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy. Cell Cycle (Georgetown, Tex.). 7: 1870-9. PMID 18594199 DOI: 10.4161/Cc.7.12.6161 |
0.528 |
|
| 2008 |
Finkin S, Aylon Y, Anzi S, Oren M, Shaulian E. Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy. Oncogene. 27: 4411-4421. PMID 18391985 DOI: 10.1038/Onc.2008.77 |
0.53 |
|
| 2008 |
Abe Y, Oda-Sato E, Tobiume K, Kawauchi K, Taya Y, Okamoto K, Oren M, Tanaka N. Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Proceedings of the National Academy of Sciences of the United States of America. 105: 4838-43. PMID 18359851 DOI: 10.1073/Pnas.0712216105 |
0.518 |
|
| 2008 |
Minsky N, Shema E, Field Y, Schuster M, Segal E, Oren M. Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells. Nature Cell Biology. 10: 483-8. PMID 18344985 DOI: 10.1038/Ncb1712 |
0.396 |
|
| 2007 |
Raver-Shapira N, Oren M. Tiny actors, great roles: microRNAs in p53's service. Cell Cycle (Georgetown, Tex.). 6: 2656-61. PMID 17957137 DOI: 10.4161/Cc.6.21.4915 |
0.407 |
|
| 2007 |
Lu X, Ma O, Nguyen TA, Jones SN, Oren M, Donehower LA. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell. 12: 342-54. PMID 17936559 DOI: 10.1016/J.Ccr.2007.08.033 |
0.576 |
|
| 2007 |
Lantner F, Starlets D, Gore Y, Flaishon L, Yamit-Hezi A, Dikstein R, Leng L, Bucala R, Machluf Y, Oren M, Shachar I. CD74 induces TAp63 expression leading to B-cell survival. Blood. 110: 4303-11. PMID 17846227 DOI: 10.1182/Blood-2007-04-087486 |
0.34 |
|
| 2007 |
Aylon Y, Oren M. Living with p53, dying of p53. Cell. 130: 597-600. PMID 17719538 DOI: 10.1016/J.Cell.2007.08.005 |
0.466 |
|
| 2007 |
Oberst A, Malatesta M, Aqeilan RI, Rossi M, Salomoni P, Murillas R, Sharma P, Kuehn MR, Oren M, Croce CM, Bernassola F, Melino G. The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch. Proceedings of the National Academy of Sciences of the United States of America. 104: 11280-5. PMID 17592138 DOI: 10.1073/Pnas.0701773104 |
0.443 |
|
| 2007 |
Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Molecular Cell. 26: 731-43. PMID 17540598 DOI: 10.1016/J.Molcel.2007.05.017 |
0.744 |
|
| 2007 |
Reef S, Shifman O, Oren M, Kimchi A. The autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 protein. Oncogene. 26: 6677-83. PMID 17486078 DOI: 10.1038/Sj.Onc.1210485 |
0.46 |
|
| 2007 |
Weisz L, Oren M, Rotter V. Transcription regulation by mutant p53 Oncogene. 26: 2202-2211. PMID 17401429 DOI: 10.1038/Sj.Onc.1210294 |
0.562 |
|
| 2007 |
Shmueli A, Oren M. Mdm2: p53's lifesaver? Molecular Cell. 25: 794-6. PMID 17386256 DOI: 10.1016/J.Molcel.2007.03.006 |
0.642 |
|
| 2007 |
Weisz L, Damalas A, Liontos M, Karakaidos P, Fontemaggi G, Maor-Aloni R, Kalis M, Levrero M, Strano S, Gorgoulis VG, Rotter V, Blandino G, Oren M. Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells. Cancer Research. 67: 2396-401. PMID 17363555 DOI: 10.1158/0008-5472.Can-06-2425 |
0.523 |
|
| 2007 |
Oren M, Bartek J. The sunny side of p53. Cell. 128: 826-8. PMID 17350568 DOI: 10.1016/J.Cell.2007.02.027 |
0.394 |
|
| 2007 |
Skorta I, van der Kuip H, Henkes M, Oren M, Aulitzky WE. Combination of Imatinib with Cisplatin and Nutlin-3: Functional and Molecular Effects on Bcr-Abl Positive Cells. Blood. 110: 2954-2954. DOI: 10.1182/Blood.V110.11.2954.2954 |
0.496 |
|
| 2006 |
Moskovits N, Kalinkovich A, Bar J, Lapidot T, Oren M. p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Research. 66: 10671-6. PMID 17108103 DOI: 10.1158/0008-5472.Can-06-2323 |
0.803 |
|
| 2006 |
Aylon Y, Michael D, Shmueli A, Yabuta N, Nojima H, Oren M. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes & Development. 20: 2687-700. PMID 17015431 DOI: 10.1101/Gad.1447006 |
0.743 |
|
| 2006 |
Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M, Rotter V. Regulation of AIF expression by p53. Cell Death and Differentiation. 13: 2140-9. PMID 16729031 DOI: 10.1038/Sj.Cdd.4401965 |
0.56 |
|
| 2006 |
Reef S, Zalckvar E, Shifman O, Bialik S, Sabanay H, Oren M, Kimchi A. A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Molecular Cell. 22: 463-75. PMID 16713577 DOI: 10.1016/J.Molcel.2006.04.014 |
0.454 |
|
| 2006 |
Avkin S, Sevilya Z, Toube L, Geacintov N, Chaney SG, Oren M, Livneh Z. p53 and p21 regulate error-prone DNA repair to yield a lower mutation load. Molecular Cell. 22: 407-13. PMID 16678112 DOI: 10.1016/J.Molcel.2006.03.022 |
0.479 |
|
| 2006 |
Margalit O, Amram H, Amariglio N, Simon AJ, Shaklai S, Granot G, Minsky N, Shimoni A, Harmelin A, Givol D, Shohat M, Oren M, Rechavi G. BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma. Blood. 107: 1599-607. PMID 16249378 DOI: 10.1182/Blood-2005-04-1629 |
0.539 |
|
| 2006 |
Zalcenstein A, Weisz L, Stambolsky P, Bar J, Rotter V, Oren M. Repression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53. Oncogene. 25: 359-69. PMID 16170349 DOI: 10.1038/Sj.Onc.1209061 |
0.52 |
|
| 2006 |
Oren M. 234 INVITED Tumor suppression by p53: inside and outside the cancer cell European Journal of Cancer Supplements. 4: 76. DOI: 10.1016/S1359-6349(06)70239-7 |
0.413 |
|
| 2005 |
Müller M, Schilling T, Sayan AE, Kairat A, Lorenz K, Schulze-Bergkamen H, Oren M, Koch A, Tannapfel A, Stremmel W, Melino G, Krammer PH. TAp73/ΔNp73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma Cell Death & Differentiation. 12: 1564-1577. PMID 16195739 DOI: 10.1038/Sj.Cdd.4401774 |
0.428 |
|
| 2005 |
Shmueli A, Oren M. Life, death, and ubiquitin: taming the mule. Cell. 121: 963-5. PMID 15989944 DOI: 10.1016/J.Cell.2005.06.018 |
0.637 |
|
| 2005 |
Gressner O, Schilling T, Lorenz K, Schulze Schleithoff E, Koch A, Schulze-Bergkamen H, Lena AM, Candi E, Terrinoni A, Catani MV, Oren M, Melino G, Krammer PH, Stremmel W, Müller M. TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. The Embo Journal. 24: 2458-71. PMID 15944736 DOI: 10.1038/Sj.Emboj.7600708 |
0.404 |
|
| 2005 |
Bar J, Lukaschuk N, Zalcenstein A, Wilder S, Seger R, Oren M. The PI3K inhibitor LY294002 prevents p53 induction by DNA damage and attenuates chemotherapy-induced apoptosis. Cell Death and Differentiation. 12: 1578-87. PMID 15933740 DOI: 10.1038/Sj.Cdd.4401677 |
0.491 |
|
| 2005 |
Oberst A, Rossi M, Salomoni P, Pandolfi PP, Oren M, Melino G, Bernassola F. Regulation of the p73 protein stability and degradation. Biochemical and Biophysical Research Communications. 331: 707-12. PMID 15865926 DOI: 10.1016/J.Bbrc.2005.03.158 |
0.586 |
|
| 2005 |
Hershko T, Chaussepied M, Oren M, Ginsberg D. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death & Differentiation. 12: 377-383. PMID 15706352 DOI: 10.1038/Sj.Cdd.4401575 |
0.532 |
|
| 2005 |
Wohlbold L, van der Kuip H, Moehring A, Granot G, Oren M, Vornlocher HP, Aulitzky WE. All common p210 and p190 Bcr-abl variants can be targeted by RNA interference. Leukemia. 19: 290-2. PMID 15565163 DOI: 10.1038/Sj.Leu.2403603 |
0.438 |
|
| 2005 |
Damalas A, Weis L, Nordgard S, Kristensen V, Gardner K, Cheng G, Gelinas C, Levrero M, Strano S, Børresen-Dale A, Rotter V, Oren M, Blandino G. Mutant p53 exerts its gain of function through activation of the NF-κB pathway Breast Cancer Research. 7. DOI: 10.1186/Bcr1176 |
0.513 |
|
| 2004 |
Weisz L, Zalcenstein A, Stambolsky P, Cohen Y, Goldfinger N, Oren M, Rotter V. Transactivation of the EGR1 gene contributes to mutant p53 gain of function. Cancer Research. 64: 8318-27. PMID 15548700 DOI: 10.1158/0008-5472.Can-04-1145 |
0.568 |
|
| 2004 |
Minsky N, Oren M. The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. Molecular Cell. 16: 631-9. PMID 15546622 DOI: 10.1016/J.Molcel.2004.10.016 |
0.468 |
|
| 2004 |
Daniely Y, Liao G, Dixon D, Linnoila RI, Lori A, Randell SH, Oren M, Jetten AM. Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium. American Journal of Physiology. Cell Physiology. 287: C171-81. PMID 15189821 DOI: 10.1152/Ajpcell.00226.2003 |
0.357 |
|
| 2004 |
Levina E, Oren M, Ben-Ze'ev A. Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics. Oncogene. 23: 4444-53. PMID 15064706 DOI: 10.1038/Sj.Onc.1207587 |
0.324 |
|
| 2004 |
Wang X, Taplick J, Geva N, Oren M. Inhibition of p53 degradation by Mdm2 acetylation. Febs Letters. 561: 195-201. PMID 15013777 DOI: 10.1016/S0014-5793(04)00168-1 |
0.561 |
|
| 2004 |
Fiucci G, Beaucourt S, Duflaut D, Lespagnol A, Stumptner-Cuvelette P, Géant A, Buchwalter G, Tuynder M, Susini L, Lassalle JM, Wasylyk C, Wasylyk B, Oren M, Amson R, Telerman A. Siah-1b is a direct transcriptional target of p53: identification of the functional p53 responsive element in the siah-1b promoter. Proceedings of the National Academy of Sciences of the United States of America. 101: 3510-5. PMID 14985507 DOI: 10.1073/Pnas.0400177101 |
0.507 |
|
| 2004 |
Bar J, Cohen-Noyman E, Geiger B, Oren M. Attenuation of the p53 response to DNA damage by high cell density. Oncogene. 23: 2128-37. PMID 14755247 DOI: 10.1038/Sj.Onc.1207325 |
0.528 |
|
| 2004 |
Shmueli A, Oren M. Regulation of p53 by Mdm2: fate is in the numbers. Molecular Cell. 13: 4-5. PMID 14731389 DOI: 10.1016/S1097-2765(03)00529-X |
0.756 |
|
| 2004 |
Wohlbold L, van der Kuip H, Moehring A, Granot G, Oren M, Vornlocher H, Aulitzky WE. Repeated Application of Sequence-Specific SiRNA Molecules Leads to an Effective Downmodulation of All Clinically Relevant bcr-abl Gene Variants. Blood. 104: 4319-4319. DOI: 10.1182/Blood.V104.11.4319.4319 |
0.343 |
|
| 2003 |
Zalcenstein A, Stambolsky P, Weisz L, Müller M, Wallach D, Goncharov TM, Krammer PH, Rotter V, Oren M. Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants. Oncogene. 22: 5667-76. PMID 12944915 DOI: 10.1038/Sj.Onc.1206724 |
0.482 |
|
| 2003 |
Wang X, Zalcenstein A, Oren M. Nitric oxide promotes p53 nuclear retention and sensitizes neuroblastoma cells to apoptosis by ionizing radiation Cell Death and Differentiation. 10: 468-476. PMID 12719724 DOI: 10.1038/Sj.Cdd.4401181 |
0.56 |
|
| 2003 |
Oren M. Decision making by p53: Life, death and cancer Cell Death and Differentiation. 10: 431-442. PMID 12719720 DOI: 10.1038/Sj.Cdd.4401183 |
0.578 |
|
| 2003 |
Passer BJ, Nancy-Portebois V, Amzallag N, Prieur S, Cans C, Roborel de Climens A, Fiucci G, Bouvard V, Tuynder M, Susini L, Morchoisne S, Crible V, Lespagnol A, Dausset J, Oren M, et al. The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Proceedings of the National Academy of Sciences of the United States of America. 100: 2284-9. PMID 12606722 DOI: 10.1073/Pnas.0530298100 |
0.537 |
|
| 2003 |
Lavon I, Pikarsky E, Gutkovich E, Goldberg I, Bar J, Oren M, Ben-Neriah Y. Nuclear factor-kappaB protects the liver against genotoxic stress and functions independently of p53. Cancer Research. 63: 25-30. PMID 12517772 |
0.307 |
|
| 2003 |
Ofek P, Ben-Meir D, Kariv-Inbal Z, Oren M, Lavi S. Cell cycle regulation and p53 activation by protein phosphatase 2C alpha. The Journal of Biological Chemistry. 278: 14299-305. PMID 12514180 DOI: 10.1074/Jbc.M211699200 |
0.579 |
|
| 2003 |
Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Seminars in Cancer Biology. 13: 49-58. PMID 12507556 DOI: 10.1016/S1044-579X(02)00099-8 |
0.539 |
|
| 2002 |
Oren M, Damalas A, Gottlieb T, Michael D, Taplick J, Leal JF, Maya R, Moas M, Seger R, Taya Y, Ben-Ze'Ev A. Regulation of p53: intricate loops and delicate balances. Annals of the New York Academy of Sciences. 973: 374-83. PMID 12485897 DOI: 10.1111/J.1749-6632.2002.Tb04669.X |
0.559 |
|
| 2002 |
Blander G, Zalle N, Daniely Y, Taplick J, Gray MD, Oren M. DNA damage-induced translocation of the Werner helicase is regulated by acetylation. The Journal of Biological Chemistry. 277: 50934-40. PMID 12384494 DOI: 10.1074/Jbc.M210479200 |
0.408 |
|
| 2002 |
Balass M, Kalef E, Maya R, Wilder S, Oren M, Katchalski-Katzir E. Characterization of two peptide epitopes on Mdm2 oncoprotein that affect p53 degradation. Peptides. 23: 1719-25. PMID 12383858 DOI: 10.1016/S0196-9781(02)00147-X |
0.33 |
|
| 2002 |
Courtois S, Verhaegh G, North S, Luciani MG, Lassus P, Hibner U, Oren M, Hainaut P. DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53. Oncogene. 21: 6722-8. PMID 12360399 DOI: 10.1038/Sj.Onc.1205874 |
0.582 |
|
| 2002 |
Oren M, Damalas A, Gottlieb T, Michael D, Taplick J, Leal JF, Maya R, Moas M, Seger R, Taya Y, Ben-Ze'ev A. Regulation of p53: intricate loops and delicate balances. Biochemical Pharmacology. 64: 865-71. PMID 12213580 DOI: 10.1016/S0006-2952(02)01149-8 |
0.558 |
|
| 2002 |
Goldberg Z, Vogt Sionov R, Berger M, Zwang Y, Perets R, Van Etten RA, Oren M, Taya Y, Haupt Y. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. The Embo Journal. 21: 3715-27. PMID 12110584 DOI: 10.1093/Emboj/Cdf384 |
0.491 |
|
| 2002 |
Folberg-Blum A, Sapir A, Shilo BZ, Oren M. Overexpression of mouse Mdm2 induces developmental phenotypes in Drosophila. Oncogene. 21: 2413-7. PMID 11948425 DOI: 10.1038/Sj.Onc.1205305 |
0.5 |
|
| 2002 |
Strano S, Fontemaggi G, Costanzo A, Rizzo MG, Monti O, Baccarini A, Del Sal G, Levrero M, Sacchi A, Oren M, Blandino G. Physical interaction with human tumor-derived p53 mutants inhibits p63 activities. The Journal of Biological Chemistry. 277: 18817-26. PMID 11893750 DOI: 10.1074/Jbc.M201405200 |
0.596 |
|
| 2002 |
Wang X, Michael D, de Murcia G, Oren M. p53 Activation by nitric oxide involves down-regulation of Mdm2. The Journal of Biological Chemistry. 277: 15697-702. PMID 11867628 DOI: 10.1074/Jbc.M112068200 |
0.575 |
|
| 2002 |
Gottlieb TM, Leal JF, Seger R, Taya Y, Oren M. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene. 21: 1299-303. PMID 11850850 DOI: 10.1038/Sj.Onc.1205181 |
0.498 |
|
| 2002 |
Michael D, Oren M. The p53 and Mdm2 families in cancer. Current Opinion in Genetics & Development. 12: 53-9. PMID 11790555 DOI: 10.1016/S0959-437X(01)00264-7 |
0.436 |
|
| 2001 |
Oren M. The p53 saga: the good, the bad, and the dead Harvey Lectures. 97: 57-82. PMID 14562517 |
0.408 |
|
| 2001 |
Susini L, Passer BJ, Amzallag-Elbaz N, Juven-Gershon T, Prieur S, Privat N, Tuynder M, Gendron MC, Israël A, Amson R, Oren M, Telerman A. Siah-1 binds and regulates the function of Numb. Proceedings of the National Academy of Sciences of the United States of America. 98: 15067-72. PMID 11752454 DOI: 10.1073/Pnas.261571998 |
0.42 |
|
| 2001 |
Sadot E, Geiger B, Oren M, Ben-Ze'ev A. Down-regulation of beta-catenin by activated p53. Molecular and Cellular Biology. 21: 6768-81. PMID 11564862 DOI: 10.1128/Mcb.21.20.6768-6781.2001 |
0.371 |
|
| 2001 |
Damalas A, Kahan S, Shtutman M, Ben‐Ze'ev A, Oren M. Deregulated β‐catenin induces a p53‐ and ARF‐dependent growth arrest and cooperates with Ras in transformation The Embo Journal. 20: 4912-4922. PMID 11532955 DOI: 10.1093/Emboj/20.17.4912 |
0.449 |
|
| 2001 |
Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, Moas M, Buschmann T, Ronai Z, Shiloh Y, Kastan MB, Katzir E, Oren M. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes & Development. 15: 1067-77. PMID 11331603 DOI: 10.1101/Gad.886901 |
0.49 |
|
| 2001 |
Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A, Oren M, Sudol M, Cesareni G, Blandino G. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. The Journal of Biological Chemistry. 276: 15164-73. PMID 11278685 DOI: 10.1074/Jbc.M010484200 |
0.494 |
|
| 2001 |
Oren M. Tumor suppressor perspective Experimental Cell Research. 264: 1. PMID 11237518 DOI: 10.1006/Excr.2000.5147 |
0.332 |
|
| 2001 |
Strano S, Fontemaggi G, Costanzo A, Rizzo MG, Levrero M, Sacchi A, Oren M, Blandino G. The p53 family: What implications in human carcinogenesis? European Journal of Cancer. 37. DOI: 10.1016/S0959-8049(01)81002-9 |
0.385 |
|
| 2001 |
Oren M, Kahan S, Shutah M, Zhurinsky J, Geiger B, Ben-Zeév A, Damalas A. Regulation of p53 activity: the cancer connection European Journal of Cancer. 37: S138. DOI: 10.1016/S0959-8049(01)81001-7 |
0.469 |
|
| 2000 |
Reinstein E, Scheffner M, Oren M, Ciechanover A, Schwartz A. Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: Targeting via ubiquitination of the N-terminal residue Oncogene. 19: 5944-5950. PMID 11127826 DOI: 10.1038/Sj.Onc.1203989 |
0.323 |
|
| 2000 |
Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M, McCormick F. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell. 103: 321-30. PMID 11057904 DOI: 10.1016/S0092-8674(00)00123-9 |
0.513 |
|
| 2000 |
Blander G, Zalle N, Leal JF, Bar-Or RL, Yu CE, Oren M. The Werner syndrome protein contributes to induction of p53 by DNA damage. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 14: 2138-40. PMID 11023999 DOI: 10.1096/Fj.00-0171Fje |
0.53 |
|
| 2000 |
Lev Bar-Or R, Maya R, Segel LA, Alon U, Levine AJ, Oren M. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proceedings of the National Academy of Sciences of the United States of America. 97: 11250-5. PMID 11016968 DOI: 10.1073/Pnas.210171597 |
0.529 |
|
| 2000 |
Maya R, Oren M. Unmasking of phosphorylation-sensitive epitopes on p53 and Mdm2 by a simple Western-phosphatase procedure Oncogene. 19: 3213-3215. PMID 10918576 DOI: 10.1038/Sj.Onc.1203658 |
0.327 |
|
| 2000 |
Strano S, Munarriz E, Rossi M, Cristofanelli B, Shaul Y, Castagnoli L, Levine AJ, Sacchi A, Cesareni G, Oren M, Blandino G. Physical and functional interaction between p53 mutants and different isoforms of p73. The Journal of Biological Chemistry. 275: 29503-12. PMID 10884390 DOI: 10.1074/Jbc.M003360200 |
0.588 |
|
| 2000 |
Amson R, Lassalle JM, Halley H, Prieur S, Lethrosne F, Roperch JP, Israeli D, Gendron MC, Duyckaerts C, Checler F, Dausset J, Cohen D, Oren M, Telerman A. Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 97: 5346-50. PMID 10805794 DOI: 10.1073/Pnas.97.10.5346 |
0.501 |
|
| 2000 |
de Rozieres S, Maya R, Oren M, Lozano G. The loss of mdm2 induces p53-mediated apoptosis. Oncogene. 19: 1691-7. PMID 10763826 DOI: 10.1038/Sj.Onc.1203468 |
0.572 |
|
| 1999 |
Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y, Shkedy D. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage Proceedings of the National Academy of Sciences of the United States of America. 96: 14973-14977. PMID 10611322 DOI: 10.1073/Pnas.96.26.14973 |
0.515 |
|
| 1999 |
Oren M. Regulation of the p53 tumor suppressor protein Journal of Biological Chemistry. 274: 36031-36034. PMID 10593882 DOI: 10.1074/Jbc.274.51.36031 |
0.51 |
|
| 1999 |
Blander G, Kipnis J, Leal JF, Yu CE, Schellenberg GD, Oren M. Physical and functional interaction between p53 and the Werner's syndrome protein. The Journal of Biological Chemistry. 274: 29463-9. PMID 10506209 DOI: 10.1074/Jbc.274.41.29463 |
0.554 |
|
| 1999 |
Roperch JP, Lethrone F, Prieur S, Piouffre L, Israeli D, Tuynder M, Nemani M, Pasturaud P, Gendron MC, Dausset J, Oren M, Amson RB, Telerman A. SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1). Proceedings of the National Academy of Sciences of the United States of America. 96: 8070-3. PMID 10393949 DOI: 10.1073/Pnas.96.14.8070 |
0.54 |
|
| 1999 |
Agami R, Blandino G, Oren M, Shaul Y. Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature. 399: 809-13. PMID 10391250 DOI: 10.1038/21697 |
0.44 |
|
| 1999 |
Unger T, Sionov RV, Moallem E, Yee CL, Howley PM, Oren M, Haupt Y. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene. 18: 3205-12. PMID 10359526 DOI: 10.1038/Sj.Onc.1202656 |
0.546 |
|
| 1999 |
Damalas A, Ben-Ze'ev A, Simcha I, Shtutman M, Leal JF, Zhurinsky J, Geiger B, Oren M. Excess beta-catenin promotes accumulation of transcriptionally active p53. The Embo Journal. 18: 3054-63. PMID 10357817 DOI: 10.1093/Emboj/18.11.3054 |
0.445 |
|
| 1999 |
Zeng X, Chen L, Jost CA, Maya R, Keller D, Wang X, Kaelin WG, Oren M, Chen J, Lu H. MDM2 suppresses p73 function without promoting p73 degradation Molecular and Cellular Biology. 19: 3257-3266. PMID 10207051 DOI: 10.1128/Mcb.19.5.3257 |
0.572 |
|
| 1999 |
Juven-Gershon T, Oren M. MDM2: The ups and downs Molecular Medicine. 5: 71-83. PMID 10203572 DOI: 10.1007/Bf03402141 |
0.413 |
|
| 1999 |
Unger T, Juven-Gershon T, Moallem E, Berger M, Vogt Sionov R, Lozano G, Oren M, Haupt Y. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. The Embo Journal. 18: 1805-14. PMID 10202144 DOI: 10.1093/Emboj/18.7.1805 |
0.55 |
|
| 1999 |
Sionov RV, Moallem E, Berger M, Kazaz A, Gerlitz O, Ben-Neriah Y, Oren M, Haupt Y. c-Abl neutralizes the inhibitory effect of Mdm2 on p53. The Journal of Biological Chemistry. 274: 8371-4. PMID 10085066 DOI: 10.1074/Jbc.274.13.8371 |
0.542 |
|
| 1999 |
Elkeles A, Juven-Gershon T, Israeli D, Wilder S, Zalcenstein A, Oren M. The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor. Molecular and Cellular Biology. 19: 2594-600. PMID 10082525 DOI: 10.1128/Mcb.19.4.2594 |
0.535 |
|
| 1999 |
Oren M, Rotter V. Introduction. p53: The first twenty years Cellular and Molecular Life Sciences. 55: 9-11. PMID 10065147 DOI: 10.1007/S000180050265 |
0.551 |
|
| 1999 |
Blandino G, Levine AJ, Oren M. Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy. Oncogene. 18: 477-85. PMID 9927204 DOI: 10.1038/Sj.Onc.1202314 |
0.521 |
|
| 1998 |
Müller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M, Krammer PH. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. The Journal of Experimental Medicine. 188: 2033-45. PMID 9841917 DOI: 10.1084/Jem.188.11.2033 |
0.489 |
|
| 1998 |
Hosokawa K, Aharoni D, Dantes A, Shaulian E, Schere-Levy C, Atzmon R, Kotsuji F, Oren M, Vlodavsky I, Amsterdam A. Modulation of Mdm2 expression and p53-induced apoptosis in immortalized human ovarian granulosa cells. Endocrinology. 139: 4688-4700. PMID 9794481 DOI: 10.1210/Endo.139.11.6280 |
0.522 |
|
| 1998 |
Wang Y, Blandino G, Oren M, Givol D. Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs Oncogene. 17: 1923-1930. PMID 9788435 DOI: 10.1038/Sj.Onc.1202113 |
0.493 |
|
| 1998 |
Yardley G, Zauberman A, Oren M, Jackson P. Individual promoter and intron p53-binding motifs from the rat Cyclin G1 promoter region support transcriptional activation by p53 but do not show co-operative activation. Febs Letters. 430: 171-5. PMID 9688532 DOI: 10.1016/S0014-5793(98)00650-4 |
0.492 |
|
| 1998 |
Gottlieb E, Oren M. p53 facilitates pRb cleavage in IL-3-deprived cells: Novel pro-apoptotic activity of p53 Embo Journal. 17: 3587-3596. PMID 9649429 DOI: 10.1093/Emboj/17.13.3587 |
0.46 |
|
| 1998 |
Juven-Gershon T, Shifman O, Unger T, Elkeles A, Haupt Y, Oren M. The Mdm2 Oncoprotein Interacts with the Cell Fate Regulator Numb Molecular and Cellular Biology. 18: 3974-3982. PMID 9632782 DOI: 10.1128/Mcb.18.7.3974 |
0.546 |
|
| 1998 |
Oren M. Teaming up to restrain cancer Nature. 391: 233-234. PMID 9440684 DOI: 10.1038/34551 |
0.464 |
|
| 1998 |
Ori A, Zauberman A, Doitsh G, Paran N, Oren M, Shaul Y. p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53. The Embo Journal. 17: 544-53. PMID 9430645 DOI: 10.1093/Emboj/17.2.544 |
0.507 |
|
| 1997 |
Gottlieb TM, Oren M. p53 and apoptosis Seminars in Cancer Biology. 8: 359-368. PMID 10101801 DOI: 10.1006/Scbi.1998.0098 |
0.523 |
|
| 1997 |
Zauberman A, Oren M, Zipori D. Involvement of p21(WAF1/Cip1), CDK4 and Rb in activin A mediated signaling leading to hepatoma cell growth inhibition Oncogene. 15: 1705-1711. PMID 9349504 DOI: 10.1038/Sj.Onc.1201348 |
0.515 |
|
| 1997 |
Oren M. Lonely no more: P53 finds its kin in a tumor suppressor haven Cell. 90: 829-832. PMID 9298894 DOI: 10.1016/S0092-8674(00)80347-5 |
0.523 |
|
| 1997 |
Israeli D, Tessler E, Haupt Y, Elkeles A, Wilder S, Amson R, Telerman A, Oren M. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. The Embo Journal. 16: 4384-92. PMID 9250682 DOI: 10.1093/Emboj/16.14.4384 |
0.56 |
|
| 1997 |
Friedman SL, Shaulian E, Littlewood T, Resnitzky D, Oren M. Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells. Oncogene. 15: 63-70. PMID 9233778 DOI: 10.1038/Sj.Onc.1201149 |
0.558 |
|
| 1997 |
Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 387: 296-9. PMID 9153395 DOI: 10.1038/387296A0 |
0.583 |
|
| 1997 |
Gottlieb E, Haffner R, King A, Asher G, Gruss P, Lonai P, Oren M. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis. The Embo Journal. 16: 1381-90. PMID 9135153 DOI: 10.1093/Emboj/16.6.1381 |
0.543 |
|
| 1997 |
Ruaro EM, Collavin L, Del Sal G, Haffner R, Oren M, Levine AJ, Schneider C. A proline-rich motif in p53 is required for transactivation-independent growth arrest as induced by Gas1. Proceedings of the National Academy of Sciences of the United States of America. 94: 4675-80. PMID 9114050 DOI: 10.1073/Pnas.94.9.4675 |
0.523 |
|
| 1997 |
Hansen R, Oren M. p53; from inductive signal to cellular effect Current Opinion in Genetics and Development. 7: 46-51. PMID 9024633 DOI: 10.1016/S0959-437X(97)80108-6 |
0.513 |
|
| 1997 |
Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature. 382: 816-8. PMID 8752276 DOI: 10.1038/382816A0 |
0.522 |
|
| 1996 |
Oren M, Prives C. p53: Upstream, downstream and off stream. Review of the 8th p53 workshop (Dundee, July 5-9, 1996) Biochimica Et Biophysica Acta - Reviews On Cancer. 1288. PMID 9011182 DOI: 10.1016/S0304-419X(96)00030-3 |
0.474 |
|
| 1996 |
Haupt Y, Oren M. p53-mediated apoptosis: mechanisms and regulation Behring Institute Mitteilungen. 32-59. PMID 8950466 |
0.475 |
|
| 1996 |
Bowman T, Symonds H, Gu L, Yin C, Oren M, Van Dyke T. Tissue-specific inactivation of p53 tumor suppression in the mouse. Genes & Development. 10: 826-35. PMID 8846919 DOI: 10.1101/Gad.10.7.826 |
0.557 |
|
| 1996 |
Gottlieb E, Lindner S, Oren M. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells Cell Growth and Differentiation. 7: 301-310. PMID 8838860 |
0.4 |
|
| 1996 |
Nemani M, Linares-Cruz G, Bruzzoni-Giovanelli H, Roperch JP, Tuynder M, Bougueleret L, Cherif D, Medhioub M, Pasturaud P, Alvaro V, der Sarkissan H, Cazes L, Le Paslier D, Le Gall I, Israeli D, ... ... Oren M, et al. Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. Proceedings of the National Academy of Sciences of the United States of America. 93: 9039-42. PMID 8799150 DOI: 10.1073/Pnas.93.17.9039 |
0.422 |
|
| 1996 |
Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M. p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells Molecular and Cellular Biology. 16: 5178-5185. PMID 8756675 DOI: 10.1128/Mcb.16.9.5178 |
0.489 |
|
| 1996 |
Friedlander P, Haupt Y, Prives C, Oren M. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis Molecular and Cellular Biology. 16: 4961-4971. PMID 8756655 DOI: 10.1128/Mcb.16.9.4961 |
0.566 |
|
| 1996 |
Gottlieb TM, Oren M. p53 in growth control and neoplasia Biochimica Et Biophysica Acta - Reviews On Cancer. 1287: 77-102. PMID 8672531 DOI: 10.1016/0304-419X(95)00019-C |
0.402 |
|
| 1996 |
Knippschild U, Oren M, Deppert W. Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion Oncogene. 12: 1755-1765. PMID 8622896 |
0.409 |
|
| 1996 |
Haupt Y, Barak Y, Oren M. Cell type-specific inhibition of p53-mediated apoptosis by mdm2 Embo Journal. 15: 1596-1606. PMID 8612583 DOI: 10.1002/J.1460-2075.1996.Tb00504.X |
0.528 |
|
| 1996 |
Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M, Vousden KH. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. The Embo Journal. 15: 827-838. DOI: 10.1002/J.1460-2075.1996.Tb00418.X |
0.566 |
|
| 1995 |
Hiebert SW, Packham G, Strom DK, Haffner R, Oren M, Zambetti G, Cleveland JL. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis Molecular and Cellular Biology. 15: 6864-6874. PMID 8524253 DOI: 10.1128/Mcb.15.12.6864 |
0.495 |
|
| 1995 |
Stuart ET, Haffner R, Oren M, Gruss P. Loss of p53 function through PAX-mediated transcriptional repression. The Embo Journal. 14: 5638-45. PMID 8521821 DOI: 10.1002/J.1460-2075.1995.Tb00251.X |
0.555 |
|
| 1995 |
Shaulian E, Haviv I, Shaul Y, Oren M. Transcriptional repression by the C-terminal domain of p53 Oncogene. 10: 671-680. PMID 7862444 |
0.377 |
|
| 1995 |
Zauberman A, Lupo A, Oren M. Identification of p53 target genes through immune selection of genomic DNA: The cyclin G gene contains two distinct p53 binding sites Oncogene. 10: 2361-2366. PMID 7784084 |
0.39 |
|
| 1995 |
Haffner R, Oren M. Biochemical properties and biological effects of p53 Current Opinion in Genetics and Development. 5: 84-90. PMID 7749331 DOI: 10.1016/S0959-437X(95)90058-6 |
0.504 |
|
| 1995 |
Keren-Tal I, Suh B, Dantes A, Lindner S, Oren M, Amsterdam A. Involvement of p53 Expression in cAMP-Mediated Apoptosis in Immortalized Granulosa Cells Experimental Cell Research. 218: 283-295. PMID 7737366 DOI: 10.1006/Excr.1995.1157 |
0.454 |
|
| 1995 |
Haupt Y, Rowan S, Oren M. p53-mediated apoptosis in HeLa cells can be overcame by excess pRB Oncogene. 10: 1563-1571. PMID 7731711 |
0.457 |
|
| 1995 |
Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M. Direct involvement of p53 in programmed cell death of oligodendrocytes Embo Journal. 14: 1136-1144. PMID 7720704 DOI: 10.1002/J.1460-2075.1995.Tb07097.X |
0.45 |
|
| 1995 |
Haupt Y, Rowan S, Shaulian E, Vousden KH, Oren M. Induction of apoptosis in HeLa cells by trans-activation-deficient p53 Genes and Development. 9: 2170-2183. PMID 7657168 DOI: 10.1101/Gad.9.17.2170 |
0.577 |
|
| 1995 |
Zauberman A, Flusberg D, Haupt Y, Barak Y, Oren M. A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Research. 23: 2584-92. PMID 7651818 DOI: 10.1093/Nar/23.14.2584 |
0.519 |
|
| 1995 |
Barak Y, Lupo A, Zauberman A, Juven T, Aloni-Grinstein R, Gottlieb E, Rotter V, Oren M. Targets for transcriptional activation by wild-type p53: endogenous retroviral LTR, immunoglobulin-like promoter, and an internal promoter of the mdm2 gene. Cold Spring Harbor Symposia On Quantitative Biology. 59: 225-35. PMID 7587074 DOI: 10.1101/Sqb.1994.059.01.027 |
0.442 |
|
| 1995 |
Malcomson RDG, Oren M, Wyllie AH, Harrison DJ. P53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs British Journal of Cancer. 72: 952-957. PMID 7547247 DOI: 10.1038/Bjc.1995.440 |
0.494 |
|
| 1995 |
Aharoni D, Dantes A, Oren M, Amsterdam A. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells Experimental Cell Research. 218: 271-282. PMID 7537693 DOI: 10.1006/Excr.1995.1156 |
0.359 |
|
| 1995 |
Haupt Y, Gottlieb E, Rowan S, Shaulian E, Oren M. 767 The role of p53 in the control of cell death European Journal of Cancer. 31: S160. DOI: 10.1016/0959-8049(95)96016-7 |
0.553 |
|
| 1994 |
Barak Y, Gottlieb E, Juven-Gershon T, Oren M. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes & Development. 8: 1739-49. PMID 7958853 DOI: 10.1101/Gad.8.15.1739 |
0.577 |
|
| 1994 |
Oren M. Relationship of p53 to the control of apoptotic cell death Seminars in Cancer Biology. 5: 221-227. PMID 7948950 |
0.414 |
|
| 1994 |
Gottlieb E, Haffner R, Rüden Tv, Wagner EF, Oren M. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. The Embo Journal. 13: 1368-1374. DOI: 10.1002/J.1460-2075.1994.Tb06390.X |
0.466 |
|
| 1993 |
Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence JJ, May P, Oren M. p53-mediated cell death: relationship to cell cycle control. Molecular and Cellular Biology. 13: 1415-23. PMID 8441387 DOI: 10.1128/Mcb.13.3.1415 |
0.498 |
|
| 1993 |
Barak Y, Juven T, Haffner R, Oren M. mdm2 expression is induced by wild type p53 activity Embo Journal. 12: 461-468. PMID 8440237 DOI: 10.1002/J.1460-2075.1993.Tb05678.X |
0.562 |
|
| 1993 |
Telerman A, Tuynder M, Dupressoir T, Robaye B, Sigaux F, Shaulian E, Oren M, Rommelaere J, Amson R. A model for tumor suppression using H-1 parvovirus. Proceedings of the National Academy of Sciences of the United States of America. 90: 8702-8706. PMID 8378352 DOI: 10.1073/Pnas.90.18.8702 |
0.436 |
|
| 1993 |
Levy N, Yonish-Rouach E, Oren M, Kimchi A. Complementation by wild-type p53 of interleukin-6 effects on M1 cells: Induction of cell cycle exit and cooperativity with c-myc suppression Molecular and Cellular Biology. 13: 7942-7952. PMID 8247009 DOI: 10.1128/Mcb.13.12.7942 |
0.446 |
|
| 1993 |
Oren M. Involvement of p53 in cell fate and cancer European Journal of Cancer. 29: S11. DOI: 10.1016/0959-8049(93)90656-Z |
0.386 |
|
| 1993 |
Zauberman A, Barak Y, Ragimov N, Levy N, Oren M. Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53 - MDM2 complexes. The Embo Journal. 12: 2799-2808. DOI: 10.1002/J.1460-2075.1993.Tb05941.X |
0.513 |
|
| 1993 |
Shaulian E, Zauberman A, Milner J, Davies EA, Oren M. Tight DNA binding and oligomerization are dispensable for the ability of p53 to transactivate target genes and suppress transformation. The Embo Journal. 12: 2789-2797. DOI: 10.1002/J.1460-2075.1993.Tb05940.X |
0.506 |
|
| 1992 |
Barak Y, Oren M. Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest Embo Journal. 11: 2115-2121. PMID 1600943 DOI: 10.1002/J.1460-2075.1992.Tb05270.X |
0.555 |
|
| 1992 |
Shaulian E, Zauberman A, Ginsberg D, Oren M. Identification of a minimal transforming domain of p53: Negative dominance through abrogation of sequence-specific DNA binding Molecular and Cellular Biology. 12: 5581-5592. PMID 1448088 DOI: 10.1128/Mcb.12.12.5581 |
0.495 |
|
| 1992 |
Oren M. p53: The ultimate tumor suppressor gene? Faseb Journal. 6: 3169-3176. PMID 1397838 DOI: 10.1096/Fasebj.6.13.1397838 |
0.591 |
|
| 1992 |
Oren M. The involvement of oncogenes and tumor suppressor genes in the control of apoptosis Cancer and Metastasis Review. 11: 141-148. PMID 1394793 DOI: 10.1007/Bf00048060 |
0.357 |
|
| 1991 |
Michalovitz D, Halevy O, Oren M. p53 mutations: Gains or losses? Journal of Cellular Biochemistry. 45: 22-29. PMID 2005181 DOI: 10.1002/Jcb.240450108 |
0.522 |
|
| 1991 |
Ginsberg D, Michael-Michalovitz D, Oren M. Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Molecular and Cellular Biology. 11: 582-585. PMID 1986251 DOI: 10.1128/Mcb.11.1.582 |
0.398 |
|
| 1991 |
Ginsberg D, Mechta F, Yaniv M, Oren M. Wild-type p53 can down-modulate the activity of various promoters Proceedings of the National Academy of Sciences of the United States of America. 88: 9979-9983. PMID 1946467 DOI: 10.1073/Pnas.88.22.9979 |
0.55 |
|
| 1991 |
Halevy O, Rodel J, Peled A, Oren M. Frequent p53 mutations in chemically induced murine fibrosarcoma Oncogene. 6: 1593-1600. PMID 1923526 |
0.39 |
|
| 1991 |
Yonish-Rouach E, Resnftzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 Nature. 352: 345-347. PMID 1852210 DOI: 10.1038/352345A0 |
0.517 |
|
| 1991 |
Eizenberg O, Oren M. Reduced levels of α1 (I) collagen mRNA in cells immortalized by mutant p53 or transformed by ras Bba - Gene Structure and Expression. 1129: 34-42. PMID 1756178 DOI: 10.1016/0167-4781(91)90209-5 |
0.396 |
|
| 1991 |
Michael-Michalovitz D, Yehiely F, Gottlieb E, Oren M. Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding Journal of Virology. 65: 4160-4168. PMID 1649323 DOI: 10.1128/Jvi.65.8.4160-4168.1991 |
0.495 |
|
| 1990 |
Halevy O, Michalovitz D, Oren M. Different tumor-derived p53 mutants exhibited distinct biological activities Science. 250: 113-116. PMID 2218501 DOI: 10.1126/Science.2218501 |
0.549 |
|
| 1990 |
Ginsberg D, Oren M, Yaniv M, Piette J. Protein-binding elements in the promoter region of the mouse p53 gene Oncogene. 5: 1285-1290. PMID 2216454 |
0.33 |
|
| 1990 |
Michalovitz D, Halevy O, Oren M. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 Cell. 62: 671-680. PMID 2143698 DOI: 10.1016/0092-8674(90)90113-S |
0.449 |
|
| 1989 |
Michalovitz D, Amsterdam A, Oren M. Interactions between SV40 and cellular oncogenes in the transformation of primary rat cells Current Topics in Microbiology and Immunology. 144: 63-75. PMID 2551593 DOI: 10.1007/978-3-642-74578-2_8 |
0.324 |
|
| 1989 |
Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, Oren M. Wild-type p53 can inhibit oncogene-mediated focus formation Proceedings of the National Academy of Sciences of the United States of America. 86: 8763-8767. PMID 2530586 DOI: 10.1073/Pnas.86.22.8763 |
0.539 |
|
| 1989 |
Halevy O, Hall A, Oren M. Stabilization of the p53 transformation-related protein in mouse fibrosarcoma cell lines: Effects of protein sequence and intracellular environment Molecular and Cellular Biology. 9: 3385-3392. PMID 2529426 DOI: 10.1128/Mcb.9.8.3385 |
0.527 |
|
| 1988 |
Kraiss S, Quaiser A, Oren M, Montenarh M. Oligomerization of oncoprotein p53 Journal of Virology. 62: 4737-4744. PMID 3054153 DOI: 10.1128/Jvi.62.12.4737-4744.1988 |
0.476 |
|
| 1988 |
Amsterdam A, Zauberman A, Meir G, Pinhasi-Kimhi O, Suh BS, Oren M. Cotransfection of granulosa cells with simian virus 40 and Ha-RAS oncogene generates stable lines capable of induced steroidogenesis. Proceedings of the National Academy of Sciences of the United States of America. 85: 7582-7586. PMID 2845413 DOI: 10.1073/Pnas.85.20.7582 |
0.356 |
|
| 1988 |
Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life Molecular and Cellular Biology. 8: 531-539. PMID 2832726 DOI: 10.1128/mcb.8.2.531-539.1988 |
0.465 |
|
| 1987 |
Oren M, Michalovitz D, Pinhasi-Kimhi O, Eliyahu D. Biological and molecular properties of p53 European Journal of Cancer and Clinical Oncology. 23: 1785. DOI: 10.1016/0277-5379(87)90669-9 |
0.417 |
|
| 1986 |
Pinhasi-Kimhi O, Michalovitz D, Ben-Zeev A, Oren M. Specific interaction between the p53 cellular tumour antigen and major heat shock proteins. Nature. 320: 182-4. PMID 3513022 DOI: 10.1038/320182A0 |
0.463 |
|
| 1986 |
Kaczmarek L, Oren M, Baserga R. Co-operation between the p53 protein tumor antigen and platelet-poor plasma in the induction of cellular DNA synthesis Experimental Cell Research. 162: 268-272. PMID 3509995 DOI: 10.1016/0014-4827(86)90445-3 |
0.46 |
|
| 1986 |
Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. Localization of gene for human p53 tumour antigen to band 17p13 Nature. 320: 84-85. PMID 3456488 DOI: 10.1038/320084A0 |
0.359 |
|
| 1986 |
Michalovitz D, Eliyahu D, Oren M. Overproduction of protein p53 contributes to simian virus 40-mediated transformation Molecular and Cellular Biology. 6: 3531-3536. PMID 3025598 DOI: 10.1128/Mcb.6.10.3531 |
0.4 |
|
| 1985 |
Rogel A, Popliker M, Webb CG, Oren M. p53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors Molecular and Cellular Biology. 5: 2851-2855. PMID 3915536 |
0.347 |
|
| 1985 |
Oren M. The p53 cellular tumor antigen: gene structure, expression and protein properties Bba - Reviews On Cancer. 823: 67-78. PMID 3902087 DOI: 10.1016/0304-419X(85)90015-0 |
0.445 |
|
| 1985 |
Eliyahu D, Michalovitz D, Oren M. Overproduction of p53 antigen makes established cells highly tumorigenic Nature. 316: 158-160. PMID 3892307 DOI: 10.1038/316158A0 |
0.501 |
|
| 1985 |
Bienz-Tadmor B, Zakut-Houri R, Libresco S, Givol D, Oren M. The 5′ region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element. The Embo Journal. 4: 3209-3213. DOI: 10.1002/J.1460-2075.1985.Tb04067.X |
0.451 |
|
| 1985 |
Zakut-Houri R, Bienz-Tadmor B, Givol D, Oren M. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. The Embo Journal. 4: 1251-1255. DOI: 10.1002/j.1460-2075.1985.tb03768.x |
0.314 |
|
| 1984 |
Czosnek HH, Bienz B, Givol D, Zakut-Houri R, Pravtcheva DD, Ruddle FH, Oren M. The gene and the pseudogene for mouse p53 cellular tumor antigen are located on different chromosomes. Molecular and Cellular Biology. 4: 1638-40. PMID 6387444 DOI: 10.1128/Mcb.4.8.1638 |
0.368 |
|
| 1984 |
Wolf D, Admon S, Oren M, Rotter V. Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species Molecular and Cellular Biology. 4: 552-558. PMID 6144042 DOI: 10.1128/Mcb.4.3.552 |
0.405 |
|
| 1984 |
Eliyahu D, Raz A, Gruss P, Givol D, Oren M. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature. 312: 646-9. PMID 6095116 DOI: 10.1038/312646A0 |
0.5 |
|
| 1984 |
Pinhasi O, Oren M. Expression of the mouse p35 cellular tumor antigen in monkey cells Molecular and Cellular Biology. 4: 2180-2186. PMID 6095045 DOI: 10.1128/Mcb.4.10.2180 |
0.521 |
|
| 1984 |
Bienz B, Zakut-Houri R, Givol D, Oren M. Analysis of the gene coding for the murine cellular tumour antigen p53. The Embo Journal. 3: 2179-2183. DOI: 10.1002/J.1460-2075.1984.Tb02110.X |
0.441 |
|
| 1983 |
Zakut-Houri R, Oren M, Bienz B, Lavie V, Hazum S, Givol D. A single gene and a pseudogene for the cellular tumour antigen p53 Nature. 306: 594-597. PMID 6646235 DOI: 10.1038/306594A0 |
0.488 |
|
| 1983 |
Reich NC, Oren M, Levine AJ. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53 Molecular and Cellular Biology. 3: 2143-2150. PMID 6318085 DOI: 10.1128/mcb.3.12.2143-2150.1983 |
0.413 |
|
| 1983 |
Oren M, Levine AJ. Molecular cloning of a cDNA specific for the murine p53 cellular tumor antigen Proceedings of the National Academy of Sciences of the United States of America. 80: 56-59. PMID 6296874 DOI: 10.1073/Pnas.80.1.56 |
0.394 |
|
| 1983 |
Oren M, Bienz B, Givol D, Rechavi G, Zakut R. Analysis of recombinant DNA clones specific for the murine p53 cellular tumor antigen. The Embo Journal. 2: 1633-1639. DOI: 10.1002/J.1460-2075.1983.Tb01637.X |
0.482 |
|
| 1982 |
Oren M, Reich NC, Levine AJ. Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny Molecular and Cellular Biology. 2: 443-449. PMID 6287239 DOI: 10.1128/mcb.2.4.443-449.1982 |
0.404 |
|
| 1982 |
Levine AJ, Kaplan L, Oren M. The regulation of a cellular protein, p53, in transformed cells and its association with viral tumor antigens Hepatology. 2. |
0.384 |
|
| 1977 |
Gluzman Y, Davison J, Oren M, Winocour E. Properties of permissive monkey cells transformed by UV-irradiated simian virus 40. Journal of Virology. 22: 256-66. PMID 194053 DOI: 10.1128/Jvi.22.2.256-266.1977 |
0.301 |
|
| Show low-probability matches. |